DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Electronic Prescribing Requirements
October 21, 2019

Click here for the new requirements requiring prescribers to generate and transmit all prescriptions electronically Continue reading


Scam Calls
September 25, 2019

Click here for more information regarding scam calls for license holders claiming to be with the Florida Board. Continue reading




Supporting Documents
Medical Degree Verification
NICA FORM
Postgraduate Training Verification